跳至主要内容
临床试验/CTRI/2025/12/098640
CTRI/2025/12/098640
招募中
不适用

Diagnostic accuracy of newly developed multicomponent peripheral Diabetic Neuropathy screening device among type 2 diabetes in the field practice area of a tertiary care hospital in Thiruvallur- A randomized control trial.

Saveetha Medical college and Hospital1 个研究点 分布在 1 个国家目标入组 281 人开始时间: 2026年1月1日最近更新:

概览

阶段
不适用
状态
招募中
发起方
Saveetha Medical college and Hospital
入组人数
281
试验地点
1
主要终点
and convenient screening particularly in underserved or resource limited areas. It is expected to prove a user friendly, practical and feasible point of care use in community and field settings providing alternate to traditional diagnosis.

概览

简要总结

This research study to validate a newly developed portable non invasive multicomponent peripheral diabetic neuropathy point of care screening device among prediabetic and type 2 diabetes in the field practice area of a tertiary care hospital in Kanchipuram. The study participants will be the individuals residing in the field practice area of the tertiary care hospital in Kanchipuram with prediabetic and type 2 diabetes. individuals will be selected based on their inclusion criteria and after getting informed consent they will be enrolled in the study. The participant can also be excluded from the study based on the exclusion criteria.  The information provided by the participant will be documented by the investigators in a proforma. This information will be recorded and compared with the results from other participating patients. No names will ever be used and data will be kept confidential. Furthermore, you may not receive any compensation, royalty, or other financial benefit that may result from any procedure.  There will be minimum or no risk to the participants while investigating into the study research.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed cases of diabetes.
  • Individuals who provide informed consent to participate in the study.

排除标准

  • 1.Individuals with type 1 diabetes.
  • Individuals with peripheral arterial disease.
  • Pregnant women and Individuals with other pre-existing conditions affecting peripheral nerves.
  • Individuals on any medication that may adversely influence peripheral nerve function
  • Participants who are unable or unwilling to provide informed consent.

结局指标

主要结局

and convenient screening particularly in underserved or resource limited areas. It is expected to prove a user friendly, practical and feasible point of care use in community and field settings providing alternate to traditional diagnosis.

时间窗: one time assessment

The expected outcome of the study is to validate the newly developed device to detect

时间窗: one time assessment

diabetic neuropathy and enable early detection even in its initial stage, improving access to affordable

时间窗: one time assessment

次要结局

  • The study seeks to contribute to the development of scalable screening programs &(healthcare policies targeting the low resource setting to reduce the burden on healthcare system &)

研究者

发起方
Saveetha Medical college and Hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Joseline Sofia Sharon

Saveetha Medical College and Hospital, Chennai.

研究点 (1)

Loading locations...

相似试验